Literature DB >> 6743469

The relaxant action of hymecromone and lignocaine on induced spasm of the bile duct sphincter.

R J McFarland, C R Corbett, P Taylor, A G Nash.   

Abstract

The retained stone in the common bile duct remains a problem for the surgeon. Although more effective methods are available, mechanical flushing of the bile duct is, when successful, a simple solution. Pharmacological dilatation of the sphincter of Oddi is a logical adjunct to flushing. Pressure changes in the bile duct during flushing were studied in 20 postoperative patients with T-tube drains and the effectiveness of two drugs in reducing Omnopon induced spasm of the sphincter was compared. Hymecromone intravenously and lignocaine via the T-tube were equally effective, reducing sphincter activity in the majority of patients, but there was considerable individual variation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743469      PMCID: PMC1463424          DOI: 10.1111/j.1365-2125.1984.tb02416.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  4 in total

1.  Nonoperative retained biliary tract stone extraction. A new roentgenologic technique.

Authors:  H J Burhenne
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-02

2.  An evaluation of cholangiomanometry with synchronous cholangiography.

Authors:  B F Ribeiro; J T Williams; W R Lees; M Roberts; L P Le Quesne
Journal:  Br J Surg       Date:  1980-12       Impact factor: 6.939

3.  [Pharmacodynamic effect of hymecromone on the sphincter of Oddi (author's transl)].

Authors:  G Ronsse; J Stalport; D Burnon
Journal:  Acta Gastroenterol Belg       Date:  1980 Jan-Feb       Impact factor: 1.316

4.  Non-operative removal of bile duct stones by duodenoscopic sphincterotomy.

Authors:  P B Cotton
Journal:  Br J Surg       Date:  1980-01       Impact factor: 6.939

  4 in total
  4 in total

1.  Biochemical, biophysical, and immunological characterization of respiratory secretions in severe SARS-CoV-2 infections.

Authors:  Michael J Kratochvil; Gernot Kaber; Sally Demirdjian; Pamela C Cai; Elizabeth B Burgener; Nadine Nagy; Graham L Barlow; Medeea Popescu; Mark R Nicolls; Michael G Ozawa; Donald P Regula; Ana E Pacheco-Navarro; Samuel Yang; Vinicio A de Jesus Perez; Harry Karmouty-Quintana; Andrew M Peters; Bihong Zhao; Maximilian L Buja; Pamela Y Johnson; Robert B Vernon; Thomas N Wight; Carlos E Milla; Angela J Rogers; Andrew J Spakowitz; Sarah C Heilshorn; Paul L Bollyky
Journal:  JCI Insight       Date:  2022-06-22

2.  Oral hymecromone decreases hyaluronan in human study participants.

Authors:  Joelle I Rosser; Nadine Nagy; Riya Goel; Gernot Kaber; Sally Demirdjian; Jamie Saxena; Jennifer B Bollyky; Adam R Frymoyer; Ana E Pacheco-Navarro; Elizabeth B Burgener; Jayakumar Rajadas; Zhe Wang; Olga Arbach; Colleen E Dunn; Anissa Kalinowski; Carlos E Milla; Paul L Bollyky
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

Review 3.  Modulation of hyaluronan signaling as a therapeutic target in human disease.

Authors:  Stavros Garantziotis
Journal:  Pharmacol Ther       Date:  2021-09-26       Impact factor: 12.310

4.  Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections.

Authors:  Michael J Kratochvil; Gernot Kaber; Sally Demirdjian; Pamela C Cai; Elizabeth B Burgener; Nadine Nagy; Graham L Barlow; Medeea Popescu; Mark R Nicolls; Michael G Ozawa; Donald P Regula; Ana E Pacheco-Navarro; Samuel Yang; Vinicio A de Jesus Perez; Harry Karmouty-Quintana; Andrew M Peters; Bihong Zhao; Maximilian L Buja; Pamela Y Johnson; Robert B Vernon; Thomas N Wight; Carlos E Milla; Angela J Rogers; Andrew J Spakowitz; Sarah C Heilshorn; Paul L Bollyky
Journal:  medRxiv       Date:  2022-04-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.